As featured in this year's Oliver Wyman Health Innovation Journal, we examine the emerging sparks beginning to define the dimensions of a new healthcare industry.
Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.
How genetics can help cut treatment costs by getting prevention services to consumers most at risk.
Why healthcare needs the new technology and how investors and innovators can take advantage of the revolution.
As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.